Evaxion Biotech (EVAX) has released an update.
Evaxion Biotech A/S has announced an amendment to the terms of warrants issued in December 2023, adjusting the exercise price for subscribing to new ordinary shares. This change is intended to align with the company’s Articles of Association and remains supplemental to the original warrant conditions. Investors holding these warrants should note the ratified terms and the amended exercise price now set in Danish Kroner.
For further insights into EVAX stock, check out TipRanks’ Stock Analysis page.
